FDA NEWS

Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial - Forbes
CALGARY, June 20 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that following U.S. Food and Drug Administration (FDA) review, the Company is initiating a U.S. Phase 2 clinical trial using
Source: www.forbes.com

GlaxoSmithKline prostate drug combination approved - Forbes
British drug maker GlaxoSmithKline PLC said Thursday the Food and Drug Administration approved its enlarged prostate drug Avodart for use in combination with Flomax, which is made by Boehringer Ingelheim Pharmaceuticals Inc. and Astellas Pharma Inc
Source: www.forbes.com

FDA Warns Companies to Stop Selling Fake Cancer Cures - Atlanta Journal Constitution
TUESDAY, June 17 (HealthDay News) -- The U.S. Food and Drug Administration has sent letters warning more than two dozen companies to stop selling fraudulent products that claim to prevent or cure cancer. The agency is also cautioning consumers not to
Source: www.ajc.com

Glenmark gets FDA nod to market anti-hypertension drug Trandolapril - CNBC
LONDON (Thomson Financial) - India's Glenmark Pharmaceuticals Ltd. said its unit Glenmark Generics Ltd. has got Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration for marketing and distribution of Trandolapril
Source: www.cnbc.com